Post-approval studies (Phase 4)Study completedNCT03554486
What this trial is testing
Evaluation of Fiasp® (Fast Acting Insulin Aspart) in 670G Hybrid Closed-Loop Therapy
Who this might be right for
Diabetes Mellitus, Type 1
Stanford University 27
Showing 20 of 0 results